Attenuation of LPS-induced iNOS expression by 1,5-anhydro-d-fructose

Biochemical and Biophysical Research Communications

Volumn 387, Issue 1, 2009, Pages 42-46

  Meng, Xiaojie ^a   Kawahara, Ko ichi ^a   Matsushita, Kenji ^b   Nawa, Yuko ^a   Shrestha, Binita ^a   Kikuchi, Kiyoshi ^a   Sameshima, Hisayo ^a   Hashiguchi, Teruto ^a   Maruyama, Ikuro ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b NATIONAL CENTER FOR GERIATRICS AND GERONTOLOGY   (Japan)

Author keywords

1,5 anhydro d fructose; Acute lung inflammation; IL 10; iNOS

Indexed keywords

1,5 ANHYDRO DEXTRO FRUCTOSE; COMPLEMENTARY DNA; CYTOKINE; FRUCTOSE; GLYCOGEN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 10; LIPOPOLYSACCHARIDE; MESSENGER RNA; MONOSACCHARIDE; STARCH; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBACTERIAL ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; FLOW CYTOMETRY; GENE EXPRESSION; IMMUNE RESPONSE; INFLAMMATION; LUNG; MACROPHAGE; MOUSE; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTIOXIDANTS; CELL LINE; FRUCTOSE; GENE EXPRESSION; INTERLEUKIN-10; LIPOPOLYSACCHARIDES; LUNG; MALE; MICE; MICE, INBRED C57BL; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; PNEUMONIA; RNA, MESSENGER;

MUS;

EID: 67651036162     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.06.108     Document Type: Article

References (31)

1. Li M., Carpio D.F., Zheng Y., Bruzzo P., Singh V., Ouaaz F., Medzhitov R.M., and Beg A.A. An essential role of the NF-kappa B/Toll-like receptor pathway in induction of inflammatory and tissue-repair gene expression by necrotic cells. J. Immunol. 166 (2001) 7128-7135
2. Petros A., Bennett D., and Vallance P. Effect of nitric oxide synthase inhibitors on hypotension in patients with septic shock. Lancet 338 (1991) 1557-1558
3. Vodovotz Y., Lucia M.S., Flanders K.C., Chesler L., Xie Q.W., Smith T.W., Weidner J., Mumford R., Webber R., Nathan C., Roberts A.B., Lippa C.F., and Sporn M.B. Inducible nitric oxide synthase in tangle-bearing neurons of patients with Alzheimer's disease. J. Exp. Med. 184 (1996) 1425-1433
4. Yu S., Bojsen K., Svensson B., and Marcussen J. Alpha-1, 4-glucan lyases producing 1, 5-anhydro-d-fructose from starch and glycogen have sequence similarity to alpha-glucosidases. Biochim. Biophys. Acta 1433 (1999) 1-15
5. Baute M.-A., Baute R., and Deffieux G. Fungal enzymic activity degrading 1, 4-[alpha]-d-glucans to 1, 5-d-anhydrofructose. Phytochemistry 27 (1988) 3401-3403
6. Broberg A., Kenne L., and Pedersen M. Analysis of 1,5-anhydro-d-fructose, microthecin, and 4-deoxy-glycero-hexo-2,3-diulose in algae using gas chromatography-mass spectrometry in selected ion monitoring mode. Anal. Biochem. 268 (1999) 35-42
7. Shiga Y., Kametani S., Kadokura T., and Akanuma H. 1, 5-Anhydroglucitol promotes glycogenolysis in Escherichia coli. J. Biochem. 125 (1999) 166-172
8. Kametani S., Shiga Y., and Akanuma H. Hepatic production of 1,5-anhydrofructose and 1,5-anhydroglucitol in rat by the third glycogenolytic pathway. Eur. J. Biochem. 242 (1996) 832-838
9. Yamaji K., Sarker K.P., Maruyama I., and Hizukuri S. Antioxidant effects of 1,5-anhydro-d-fructose a new natural sugar in vitro. Planta Med. 68 (2002) 16-19
10. Yu S., and Fiskesund R. The anhydrofructose pathway and its possible role in stress response and signaling. Biochim. Biophys. Acta 1760 (2006) 1314-1322
11. Meng X., Kawahara K., Nawa Y., Miura N., Shrestha B., Tancharoen S., Sameshima H., Hashiguchi T., and Maruyama I. 1,5-Anhydro-d-fructose attenuates lipopolysaccharide-induced cytokine release via suppression of NF-kappaB p65 phosphorylation. Biochem. Biophys. Res. Commun. 380 (2009) 343-348
12. Chow C.W., Herrera Abreu M.T., Suzuki T., and Downey G.P. Oxidative stress and acute lung injury. Am. J. Respir. Cell Mol. Biol. 29 (2003) 427-431
13. Cuzzocrea S., Mazzon E., Dugo L., Serraino I., Di Paola R., Genovese T., De Sarro A., and Caputi A.P. Absence of endogenous interleukin-10 enhances the evolution of acute lung injury. Eur. Cytokine Network 13 (2002) 285-297
14. Uto T., Fujii M., and Hou D.X. 6-(Methylsulfinyl)hexyl isothiocyanate suppresses inducible nitric oxide synthase expression through the inhibition of Janus kinase 2-mediated JNK pathway in lipopolysaccharide-activated murine macrophages. Biochem. Pharmacol. 70 (2005) 1211-1221
15. Misko T.P., Schilling R.J., Salvemini D., Moore W.M., and Currie M.G. A fluorometric assay for the measurement of nitrite in biological samples. Anal. Biochem. 214 (1993) 11-16
16. Kawahara K., Biswas K.K., Unoshima M., Ito T., Kikuchi K., Morimoto Y., Iwata M., Tancharoen S., Oyama Y., Takenouchi K., Nawa Y., Arimura N., Jie M.X., Shrestha B., Miura N., Shimizu T., Mera K., Arimura S., Taniguchi N., Iwasaka H., Takao S., Hashiguchi T., and Maruyama I. C-reactive protein induces high-mobility group box-1 protein release through activation of p38MAPK in macrophage RAW264.7 cells. Cardiovasc. Pathol. 17 (2008) 129-138
17. Epstein J.A. Currying favor for the heart. J. Clin. Invest. 118 (2008) 850-852
18. Speyer C.L., Neff T.A., Warner R.L., Guo R.F., Sarma J.V., Riedemann N.C., Murphy M.E., Murphy H.S., and Ward P.A. Regulatory effects of iNOS on acute lung inflammatory responses in mice. Am. J. Pathol. 163 (2003) 2319-2328
19. Ding A.H., Nathan C.F., and Stuehr D.J. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production. J. Immunol. 141 (1988) 2407-2412
20. Nussler A.K., and Billiar T.R. Inflammation, immunoregulation, and inducible nitric oxide synthase. J. Leukoc. Biol. 54 (1993) 171-178
21. Kawada N., Seki S., Inoue M., and Kuroki T. Effect of antioxidants. Resveratrol, quercetin, and N-acetylcysteine, on the functions of cultured rat hepatic stellate cells and Kupffer cells, Hepatology 27 (1998) 1265-1274
22. MacNee W. Oxidative stress and lung inflammation in airways disease. Eur. J. Pharmacol. 429 (2001) 195-207
23. Myers J.T., and Swanson J.A. Calcium spikes in activated macrophages during Fcgamma receptor-mediated phagocytosis. J. Leukoc. Biol. 72 (2002) 677-684
24. Gaston B., Drazen J.M., Loscalzo J., and Stamler J.S. The biology of nitrogen oxides in the airways. Am. J. Respir. Crit. Care Med. 149 (1994) 538-551
25. Lin W.W., and Karin M. A cytokine-mediated link between innate immunity, inflammation, and cancer. J. Clin. Invest. 117 (2007) 1175-1183
26. Numata M., Suzuki S., Miyazawa N., Miyashita A., Nagashima Y., Inoue S., Kaneko T., and Okubo T. Inhibition of inducible nitric oxide synthase prevents LPS-induced acute lung injury in dogs. J. Immunol. 160 (1998) 3031-3037
27. Heyen J.R., Ye S., Finck B.N., and Johnson R.W. Interleukin (IL)-10 inhibits IL-6 production in microglia by preventing activation of NF-kappaB. Brain Res. Mol. Brain Res. 77 (2000) 138-147
28. Ogando D., Cella M., Ribeiro M.L., Weissmann C., Aisemberg J., and Franchi A. IL-10 inhibits nitric oxide synthesis in murine uterus. Neuroimmunomodulation 11 (2004) 127-132
29. Donnelly S.C., Strieter R.M., Reid P.T., Kunkel S.L., Burdick M.D., Armstrong I., Mackenzie A., and Haslett C. The association between mortality rates and decreased concentrations of interleukin-10 and interleukin-1 receptor antagonist in the lung fluids of patients with the adult respiratory distress syndrome. Ann. Intern. Med. 125 (1996) 191-196
30. Lee H.S., Moon C., Lee H.W., Park E.M., Cho M.S., and Kang J.L. Src tyrosine kinases mediate activations of NF-kappaB and integrin signal during lipopolysaccharide-induced acute lung injury. J. Immunol. 179 (2007) 7001-7011
31. Al-Ashy R., Chakroun I., El-Sabban M.E., and Homaidan F.R. The role of NF-kappaB in mediating the anti-inflammatory effects of IL-10 in intestinal epithelial cells. Cytokine 36 (2006) 1-8